NCT01435200View on ClinicalTrials.gov

Intravenous Iron in Gynecologic Cancer Patients Receiving Chemotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

November 30, 2012

Conditions
Gynecologic Cancer
Interventions
DRUG

Intravenous iron

Intravenous iron 200 mg add in 0.9% Normal saline 100 ml infused within 15 minutes after every cycles of chemotherapy

Trial Locations (1)

10330

Chulalongkorn Hospital, Bangkok

All Listed Sponsors
lead

Chulalongkorn University

OTHER

NCT01435200 - Intravenous Iron in Gynecologic Cancer Patients Receiving Chemotherapy | Biotech Hunter | Biotech Hunter